Skip to main content
Watch Insiders
VRDNHealthcare

Viridian Therapeutics Inc (VRDN) Insider Trading

In the last 90 days, 1 Viridian Therapeutics Inc (VRDN) insider reported no open-market purchases and 1 sale totaling $348,194. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 19, 2026Jennifer TousignantChief Legal OfficerSale14,212$24.50$348,194
May 11, 2026Fairmount Healthcare Fund II L.P.Corporate insiderOpen Market Purchase1,176,470$17.00$19,999,990
May 11, 2026Fairmount Funds Management LLCCorporate insiderOpen Market Purchase1,176,470$17.00$19,999,990
May 11, 2026Fairmount Healthcare Fund II GP LLCCorporate insiderOpen Market Purchase1,176,470$17.00$19,999,990

Common questions

VRDN insider trading FAQ

Are VRDN insiders buying or selling?
Over the last 90 days, VRDN insiders were net sellers, reporting $0.00 of open-market purchases and $348,194 of sales.
When was the last VRDN insider purchase?
No open-market insider purchase of Viridian Therapeutics Inc stock was reported in the last 90 days.
Where does VRDN insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Viridian Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.